Education and Health Notices




30 AUGUST

NEW ZEALAND GAZETTE

2809

Education

Private Schools Conditional Integration Act 1975

Supplementary Integration Agreement

Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:

Sacred Heart Girls College, New Plymouth.

The said supplementary integration agreement was executed on 21 August 2001.

A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the district office of the Ministry of Education, 116 Victoria Avenue, Wanganui.

Dated at Wellington this 21st day of August 2001.

KATHY PHILLIPS, Senior Manager, National Operations.

go5954

Education Act 1989

Amendment to Extension of Term of Office of Commissioner at Kimi Ora Community School

Acting under delegated authority, pursuant to section 109 (7B) of the Education Act 1989, I hereby amend the notice published in the New Zealand Gazette, 15 March 2001, page 619, by omitting the words

“30 November 2001”

and substituting the words

“19 November 2001”.

Dated at Wellington this 22nd day of August 2001.

KATHY PHILLIPS, Senior Manager, National Operations.

go5970

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Cellugel Viscoelastic Solution

Active Ingredient(s):
Hypromellose 23mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Pacific Pharmaceuticals Limited

Manufacturer(s):
Alcon Couvreur SA, Puurs, Belgium

Product:
Dilaudid

Active Ingredient(s):
Hydromorphone hydrochloride 2mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Knoll Australia Pty Limited

Manufacturer(s):
Abbott Laboratories Inc, McPherson, Kansas, United States of America

Product:
Dilaudid

Active Ingredient(s):
Hydromorphone hydrochloride 1mg/mL

Dosage Form:
Oral solution

New Zealand Sponsor:
Knoll Australia Pty Limited

Manufacturer(s):
Knoll Pharmaceutical Company, Whippany, New Jersey, United States of America

Product:
Dilaudid

Active Ingredient(s):
Hydromorphone hydrochloride 2mg

Dosage Form:
Tablet

New Zealand Sponsor:
Knoll Australia Pty Limited

Manufacturer(s):
Knoll Pharmaceutical Company, Whippany, New Jersey, United States of America

Product:
Dilaudid

Active Ingredient(s):
Hydromorphone hydrochloride 4mg

Dosage Form:
Tablet

New Zealand Sponsor:
Knoll Australia Pty Limited

Manufacturer(s):
Knoll Pharmaceutical Company, Whippany, New Jersey, United States of America



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 109


Gazette.govt.nz PDF NZ Gazette 2001, No 109





✨ LLM interpretation of page content

🎓 Supplementary Integration Agreement for Sacred Heart Girls College

🎓 Education, Culture & Science
21 August 2001
Private Schools Conditional Integration Act 1975, Sacred Heart Girls College, New Plymouth, Supplementary Integration Agreement
  • KATHY PHILLIPS, Senior Manager, National Operations

🎓 Amendment to Extension of Term of Office of Commissioner at Kimi Ora Community School

🎓 Education, Culture & Science
22 August 2001
Education Act 1989, Kimi Ora Community School, Term of Office, Commissioner
  • KATHY PHILLIPS, Senior Manager, National Operations

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Cellugel Viscoelastic Solution, Dilaudid, Hydromorphone hydrochloride, Pacific Pharmaceuticals Limited, Knoll Australia Pty Limited